| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.094 | 0.6 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |